Ivosidenib

TIBSOVO®

Overview

Ivosidenib is a small molecule inhibitor that is approved for use in acute myeloid leukemia and cholangiocarcinoma.

SparkCures ID 583
Brand Name Tibsovo®
Generic Name Ivosidenib
Additional Names AG-120
Treatment Classifications
  • Isocitrate Dehydrogenase 1 (IDH1) Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.